The retail pharmacy chain told CNBC Nov. 5 that it is looking at its options to take the company private as it struggles to adapt to the changing pharmacy landscape. If it goes through, it would be the largest leveraged buyout in history, as Walgreens has a market value of about $53 billion and $16.8 billion in debt.
Walgreens shares jumped about 5 percent in premarket trading Nov. 11 after Bloomberg reported news of the potential deal.
The deal is not finalized, however, and it is unclear how feasible it is considering the need for large amounts of financing.
It wouldn’t be the first time New York City-based KKR partnered with Deerfield, Ill.-based Walgreens, as Walgreens CEO Stefano Pessina worked with the firm in 2007 to acquire Alliance Boots.
Read the full article here.
More articles on pharmacy:
Endo CEO to retire
Trump administration sues Gilead
CVS to close 22 ‘underperforming’ stores
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
